*The company's platform technology combines machine learning, metabolomics, and robotics to analyze a natural sample for both chemical structure and biological activity and function, eliminating the need for isolating individual compounds or conducting extensive experimentation, enabling clients in the healthcare industry to form new antibiotics to hypotensives.